ENCOMPASS HEALTH REHABILITATION HOSP — History
CCN 103037 | 3-year financial timeline | COVID resilience: 69/100
🛡️ Public data only — no PHI permitted on this instance.
$34M
Latest Revenue (FY2022)
+7.4%
Revenue CAGR (3yr)
18.3%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $30M | $33M | $34M | +4.6% | +7.4% |
| Operating Expenses | $26M | $27M | $28M | +3.0% | +3.8% |
| Operating Margin | 12.6% | 17.0% | 18.3% | +7.7% | +20.2% |
| Net Income | $4M | $6M | $6M | +12.7% | +29.1% |
| Licensed Beds | 70 | 70 | 70 | +0.0% | +0.0% |
| Total Patient Days | 21,676 | 22,313 | 22,958 | +2.9% | +2.9% |
| Medicare Day % | 63% | 62% | 62% | +0.2% | -0.5% |
| Medicaid Day % | 1% | 0% | 0% | -10.0% | -36.5% |
COVID Impact & Recovery
Resilience Score: 69/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +15.2% ($30M → $34M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+7.4%
This Hospital
+7.6%
State Avg
Latest Margin
18.3%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $37M | 21.1% |
| FY2024 (proj) | $39M | 23.9% |
| FY2025 (proj) | $41M | 26.7% |